Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.

• Egile Nagusiak: Haidi Karam-Allah Ramadan (Egilea), Waleed Attia Hassan (Egilea), Nahed Ahmed Elossily (Egilea), Alzahraa Abdelraouf Ahmad (Egilea), Adnan Ahmed Mohamed (Egilea), Alaa Soliman Abd-Elkader (Egilea), Eman M Nagiub Abdelsalam (Egilea), Hani M J Khojah (Egilea)
• Formatua: Liburua
• Argitaratua: Public Library of Science (PLoS), 2019-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<h4>Background</h4>Fascioliasis is a neglected zoonosis with major public health implications in humans. Although triclabendazole (TCBZ) is the drug of choice, there are records of TCBZ failure worldwide. TCBZ-resistant fascioliasis is treated with alternative approved drugs including ni...